After less than satisfactory ventures in India and the USA, medtech company dedicated to respiratory health Respiri (ASX: RSH) is…
Medtech company Respiri (ASX: RSH) has continued its long path towards commercialisation of its asthma diagnostics device 'wheezo', having entered…
Under new management, medtech company Respiri (ASX: RSH) is poised to enter the lucrative SaaS revenue market by leveraging their…